Literature DB >> 526816

Paediatric use of mexiletine and disopyramide.

D W Holt, A C Walsh, P V Curry, M Tynan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526816      PMCID: PMC1597172          DOI: 10.1136/bmj.2.6203.1476-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  1 in total

1.  Disopyramide: a new agent for effective therapy of ventricular dysrhythmias.

Authors:  D T Mason
Journal:  Drugs       Date:  1978-05       Impact factor: 9.546

  1 in total
  8 in total

1.  Effect of age and plasma concentrations of albumin and alpha 1-acid glycoprotein on protein binding of disopyramide.

Authors:  D W Holt; A M Hayler; G F Healey
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of disopyramide.

Authors:  A Karim; C Nissen; D L Azarnoff
Journal:  J Pharmacokinet Biopharm       Date:  1982-10

3.  Cimetidine pharmacokinetics and dosage requirements in children.

Authors:  A Somogyi; M Becker; R Gugler
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

Review 4.  Clinical pharmacokinetics of disopyramide.

Authors:  L A Siddoway; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

Review 5.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

6.  Mexiletine in human blood and breast milk.

Authors:  A M Lewis; L Patel; A Johnston; P Turner
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

7.  Disopyramide and its N-monodesalkyl metabolite in breast milk.

Authors:  D B Barnett; S A Hudson; A McBurney
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 8.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.